|
시장보고서
상품코드
1362385
체외진단(IVD) 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 범위 : 제품 및 서비스별, 기술별, 용도별, 최종사용자별, 지역별In-Vitro Diagnostic Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product & Service, Technology, Application, End User, and Geography |
||||||
체외진단 시장은 2022년 723억 9,380만 달러에서 2030년 1,121억 351만 달러로 성장할 것으로 예상되며, 2022-2030년간 연평균 5.6%의 성장률을 보일 것으로 예상됩니다. 만성 질환 증가, 기술 발전, 노령 인구 증가는 체외 진단 시장의 성장을 가속하는 주목할 만한 요인입니다.
체외진단(IVD)은 인체에서 채취한 혈액이나 조직 등의 샘플을 이용한 검사를 말합니다. 체외진단은 질병 및 기타 상태를 감지하는 데 특화되어 있으며, 질병의 치료, 치료 및 예방에 도움을 주기 위해 사람의 전반적인 건강 상태를 모니터링하는 데 사용됩니다. 또한, 체외진단은 특정 치료나 요법의 혜택을 받을 수 있는 환자를 식별하는 정밀의료에 활용되기도 합니다. 따라서 이러한 체외 진단에는 유전체 변이를 감지하기 위해 사람의 DNA를 스캔하는 차세대 염기서열 분석 검사가 포함됩니다.
만성질환 및 감염성 질환의 유병률 증가
세계적으로 감염성 질환의 유행이 급격히 증가하고 있습니다. 이러한 질병은 바이러스, 세균, 기생충 등 병원성 미생물이 주요 원인입니다. 열악한 위생 환경, 공중 위생 부족, 대기 오염 수준 증가, 안전한 식수 부족 등의 요인이 전염병 확산에 큰 역할을 하고 있습니다. 캐나다 공중보건국에 따르면 2020년 캐나다에서 총 6,736명의 C형간염 환자(급성, 만성, 미확인 환자 합계)가 보고됐습니다.
만성 질환에는 암, 만성 호흡기 질환, 당뇨병, 심장병 등이 포함됩니다. 술과 담배 증가, 건강에 해로운 식습관, 운동 부족, 비만 확산과 같은 생물학적 위험 요인으로 인해 세계적으로 이러한 질병의 발병률이 급증하고 있습니다. 만성질환은 세계 사망원인 1위입니다. 미국 질병예방통제센터(CDC)에 따르면, 미국인 10명 중 6명은 뇌졸중, 암, 심장병, 당뇨병 등 적어도 한 가지 이상의 만성질환을 앓고 있습니다. 이러한 만성질환은 미국 내 사망과 장애의 주요 원인이자 급증하는 의료비용의 주요 원인입니다. 또한 CDC 데이터에 따르면 심장병은 남성, 여성 및 대부분의 인종과 민족의 사망 원인 중 1위입니다.
CDC 데이터에 따르면 관상동맥질환(CAD)은 성인의 가장 흔한 사망 원인으로 2021년 약 375,476명이 CAD로 인해 사망했습니다. 세계보건기구(WHO)의 2022년 국가별 당뇨병 통계 보고서에 따르면 세계 4억 2,200만 명이 당뇨병을 앓고 있으며, 대다수가 중저소득 국가에 거주하고 있습니다. 또한 매년 150만 명이 당뇨병과 직접적으로 관련되어 사망하고 있습니다. 과체중, 유전적 조건, 노화, 좌식 생활습관 등이 당뇨병 유병률을 높이고 있으며, Cancer Research UK 보고서에 따르면 2020년에는 세계적으로 1,810만 명의 신규 암 환자가 보고될 것으로 예상되며, 2040년까지 2,800만 명으로 증가할 것으로 예상했습니다. 증가할 것으로 예상됩니다. 따라서 심혈관 질환, 암, 당뇨병, 호흡기 질환과 같은 감염성 및 만성 질환의 유병률 증가가 체외진단 시장 성장을 주도하고 있습니다.
시장 동향
맞춤형 의료와 유전체학에 대한 수요 증가
북미는 개인 맞춤형 의료와 유전체학 연구의 최전선에 있습니다. 유전체학 및 분자 진단이 일상적인 환자 치료에 통합되고 있습니다. 첨단 유전학 개발에 참여하는 기업들은 체외진단 시장에 큰 비즈니스 기회를 제공합니다. 북미, 특히 미국과 캐나다는 질병의 유전적 기반에 대한 이해와 지식, 바이오마커 식별, 표적치료제 개발에 크게 기여하는 유전체 연구센터의 거점입니다. 두 나라는 유전체학을 임상 진료에 통합하는 정밀의료 이니셔티브를 추진하고 있습니다. 북미는 암 유전체학의 선두주자로서 다양한 유형의 암과 관련된 유전적 요인을 규명하는 데 초점을 맞춘 광범위한 조사와 임상시험이 진행되고 있습니다. 이러한 임상시험은 환자의 종양 유전적 특성에 따라 표적 치료, 면역 요법 및 기타 혁신적인 치료법의 효과를 평가하는 것을 목표로 하고 있습니다. 미국암협회는 2023년 미국에서 190만 명의 신규 암 환자(하루 5,370명)와 609,820명의 암으로 인한 사망자가 발생할 것으로 추정하고 있습니다. 이러한 높은 이환율에 따라 이들 환자의 삶의 질을 개선할 수 있는 효과적인 치료법이 절실히 요구되고 있습니다.
맞춤형 의료는 환자에게 체외 진단 검사를 실시하여 환자별 특성에 따라 하위 그룹으로 세분화합니다. 유전체 염기서열 분석, 분자 프로파일링 및 기타 진단 기술의 발전과 함께 개인 맞춤형 의료 분야는 표적화된 정밀하고 맞춤 치료 접근법을 제공함으로써 헬스케어에 혁명을 일으킬 수 있는 잠재력을 가지고 있습니다. 2022년 11월, Roche, Cancer Research UK, 맨체스터 대학은 다제 병용 정밀의료 DETERMINE 임상시험의 시작을 발표하며 세계적으로 유전학이 점점 더 친숙해지고 있습니다. 이 시험은 일반적인 암종에 대해 승인된 약물을 포함해 희귀 암종 환자들에게 도움이 되는지 여부를 평가하는 것을 목표로 하고 있습니다. 23andMe와 AncestryDNA와 같은 회사는 소비자에게 직접 유전자 검사 키트를 제공하여 개인이 자신의 조상, 유전적 특성 및 잠재적 건강 위험에 대한 통찰력을 얻을 수 있도록 하고 있습니다. 의료 서비스 제공업체들도 치료 방침을 결정하기 위해 유전자 검사를 제공합니다. 이처럼 개인 맞춤형 의료와 유전체학에 대한 수요는 예측 기간 동안 체외진단 시장의 성장을 가속할 것으로 보입니다.
세계 체외진단 시장은 제품 및 서비스, 용도, 기술, 최종 사용자, 지역별로 분류됩니다. 제품 및 서비스를 기준으로 시장은 시약 및 키트, 기기, 소프트웨어 및 서비스로 구분되며, 2022년에는 시약 및 키트 부문이 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 시약 및 키트 시장의 성장 전망의 배경에는 자가 진단 키트 및 POC 장치의 엄청난 인기, 작업을 간소화하고 정확한 결과를 제공하는 자동화 기기의 가용성 및 도입 증가가 있습니다. 또한, 바이러스 및 곰팡이로 인한 감염 증가와 불충분한 위생 상태는 시약의 사용을 촉진하고 있습니다. 따라서 체외 진단 시장 기업은 더 나은 환자 관리 및 치료를 위해 우수한 품질의 분자 시약 및 키트를 제공합니다.
유럽의약품청, 긴급사용승인, 질병통제예방센터, 국제당뇨병연맹, 체외진단연구는 체외진단 시장 조사 보고서를 작성할 때 참고한 관련 자료 중 일부입니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
- 체외진단(IVD) 시장, 지역별
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 체외진단(IVD) 시장 구도
- PEST 분석
- PEST 분석
제5장 임상 검사 진단 시장 - 주요 산업 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 향후 동향
제6장 체외진단(IVD) 시장 - 세계 시장 분석
- 체외진단(IVD) 시장 매출, 2022년-2030년
제7장 세계의 체외진단(IVD) 시장 - 2030년까지 매출과 예측-제품 및 서비스별
- 2022년 및 2030년 체외진단(IVD) 시장 제품 및 서비스별 판매량 점유율(%)
- 시약 및 키트
- 소프트웨어 및 서비스
- 검사기기
제8장 세계의 체외진단(IVD) 시장 : 2030년까지 매출과 예측 : 기술별
- 2022년 및 2030년 체외진단(IVD) 시장 기술별 판매량 점유율(%)
- 면역측정/면역화학
- 임상화학
- 분자진단
- 미생물학
- 자가혈당측정
- 응고 및 지혈
- 혈액학
- 요검사
- 기타
제9장 체외진단 용의약품 세계 시장 - 용도별 매출과 2030년까지 예측
- 2022년 및 2030년 체외진단(IVD) 시장 용도별 판매량 점유율(%)
- 감염증
- 당뇨병
- 종양학
- 순환기
- 자가면역질환
- 신장 내과
- 기타
제10장 세계의 체외진단(IVD) 시장 : 최종사용자별 매출과 2030년까지 예측
- 체외진단(IVD) 시장 2022년 및 2030년 최종사용자별 판매량 점유율(%)
- 병원
- 연구소
- 재택치료
- 기타
제11장 지역별 분석 : 체외진단(IVD) 시장 매출과 2030년까지 예측
- 북미
- 유럽
- 아시아태평양
- 중동 및 아프리카
- 중남미
제12장 업계 상황
- 북미의 체외진단(IVD) 시장 성장 전략
- 유기적 전개
- 무기적 전개
제13장 기업 개요
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Danaher Corp
- Siemens AG
- Sysmex Corp
- Thermo Fisher Scientific Inc
- Becton Dickinson and Co
- bioMerieux SA
- Bio-Rad Laboratories Inc
- Qiagen NV
제14장 부록
LSH 23.10.24The in-vitro diagnostics market is expected to grow from US$ 72,393.80 million in 2022 to US$ 1,12,103.51 million by 2030; it is expected to grow at a CAGR of 5.6% from 2022 to 2030. The increasing prevalence of chronic diseases, technological advancements, and the growing geriatric population are the noteworthy factors driving the in-vitro diagnostics market growth.
In vitro diagnostics (IVD) are tests done on samples such as blood or tissues that have been taken from the human body. In-vitro diagnostics are specialized to detect diseases or other conditions that can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Additionally, in-vitro diagnostics may also be utilized for precision medicine to identify patients who are likely to benefit from specific treatments or therapies. Therefore, these in-vitro diagnostics can include next-generation sequencing tests that scan a person's DNA to detect genomic variations.
Increasing Prevalence of Chronic and Infectious Diseases
The world is witnessing an exponential increase in the prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Factors such as poor sanitary conditions, lack of public hygiene, elevating levels of air pollution, and unavailability of safe drinking water play a significant role in the bolstering prevalence of infectious diseases. According to the Public Health Agency of Canada, the country reported a total of 6,736 cases of hepatitis C (acute, chronic, and unspecified combined) in 2020.
Chronic diseases prominently include cancer, chronic respiratory diseases, diabetes, and heart disease. The incidences of these conditions are skyrocketing globally due to biological risk factors, such as an increase in alcohol and tobacco consumption, adoption of unhealthy diets, lack of physical activity, and prevalence of obesity. Chronic conditions are the leading cause of mortality globally. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as stroke, cancer, heart disease, or diabetes. These chronic diseases are the leading causes of death and disabilities, and burgeoning healthcare costs in the US; the country's healthcare cost was ~US$ 4.1 trillion in 2021. The CDC data also suggests that heart disease is the leading cause of death among men, women, and people of most racial and ethnic groups.
According to CDC data, coronary artery disease (CAD) is the most common cause of mortality among adults. Approximately 375,476 people died due to CAD in 2021. Estimates published in the 2022 National Diabetes Statistics Report by the World Health Organization state that ~422 million people worldwide have diabetes, the majority living in low-and middle-income countries. Moreover, 1.5 million deaths are directly related to diabetes each year. overweight, genetic conditions, aging, sedentary lifestyle, etc., are boosting the prevalence of diabetes. According to estimations published in a Cancer Research UK report, ~18.1 million new cancer cases were reported in the world in 2020, and the number is expected to increase to 28 million by 2040. Hence, the rising prevalence of infectious and chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory conditions drives the growth of the in-vitro diagnostics market.
Market Trend
Increasing Demand for Personalized Medicine and Genomics
North America is at the forefront of personalized medicine and genomics research. There is increasing integration of genomics and molecular diagnostics into routine patient care. Companies are involved in developing advanced genetics hold substantial opportunities for the in-vitro diagnostics market. North America, particularly the US and Canada, has been a hub for genomic research centers that contribute notably to understanding and knowledge on the genetic basis of diseases, identification of biomarkers, and development of targeted therapies. Both these countries have launched precision medicine initiatives to integrate genomics into clinical practices. North America has been a leader in cancer genomics, hosting extensive research and clinical trials focused on understanding the genetic factors associated with different types of cancer. These trials aim to evaluate the efficacy of targeted therapies, immunotherapies, and other innovative treatments based on the genetic characteristics of patients' tumors. The American Cancer Society estimates that the US would record 1.9 million new cancer cases (~5,370 cases per day) and 609,820 deaths from cancer in 2023. With such a high incidence, there is a pressing need for effective treatment to improve the quality of life of these patients.
Personalized medicine involves running in-vitro diagnostics tests on patients to stratify them into subgroups based on their unique characteristics. The field of personalized medicine, along with advancements in genomics sequencing, molecular profiling, and other diagnostic technologies, has the potential to revolutionize healthcare by providing targeted, precise, and individualized treatment approaches. Genetics have become increasingly accessible globally. In November 2022, Roche, Cancer Research UK, and the University of Manchester announced the launch of a multidrug, precision medicine DETERMINE trial. The trial seeks to evaluated if available agents, including those that are licensed for more common cancer types, could benefit patients with rare cancer types. The trial recruited both adult and pediatric patients with rare cancer types. Companies such as 23and Me and AncestryDNA offer direct-to-consumer genetic testing kits, allowing individuals to gain insights into their ancestry, genetic traits, and potential health risks. Healthcare providers also offer genetic testing to guide treatment decisions. Thus, the demand for personalized medicine and genomics will propel the growth of the in-vitro diagnostics market during the forecast period.
The "Global In-Vitro Diagnostic Market" is segmented on the basis of product and service, application, technology, end user, and geography. Based on product and service, the market is segmented into reagents and kits, instruments, and software and services. In 2022, the reagents and kits segment held the largest share of the market. The projected growth of the market for reagents and kits is attributed to the tremendous popularity of self-test kits and POC devices, and a rise in availability and adoption automated instruments that simplify jobs and provide accurate results. The increasing cases of viral and fungal infections with inadequate hygienic conditions promote reagent use. Thus, players in the in-vitro diagnostics market are offering superior quality molecular reagents and kits for better patient management and care.
European Medicines Agency, Emergency Use Authorization, Centers for Disease Control and Prevention, International Diabetes Federation, In-Vitro Diagnostic Research are some of the relevant sources referred while preparing the in-vitro diagnostics market research report.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the in-vitro diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global in-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
- 2.2 In-Vitro Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. In-Vitro Diagnostics Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 PEST Analysis
5. In-Vitro Diagnostics Market - Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
- 5.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
- 5.2 Market Restraint
- 5.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
- 5.3 Market Opportunities
- 5.3.1 Integration of IVD with Digital Health Technologies
- 5.4 Future Trends
- 5.4.1 Increasing Demand for Personalized Medicine and Genomics
6. In-Vitro Diagnostics Market - Global Market Analysis
- 6.1 In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030
7. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services
- 7.1 Overview
- 7.2 In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
- 7.3 Reagents and Kits
- 7.3.1 Overview
- 7.3.2 Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Software and Services
- 7.4.1 Overview
- 7.4.2 Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Instruments
- 7.5.1 Overview
- 7.5.2 Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology
- 8.1 Overview
- 8.2 In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
- 8.3 Immunoassay/ Immunochemistry
- 8.3.1 Overview
- 8.3.2 Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Clinical Chemistry
- 8.4.1 Overview
- 8.4.2 Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Molecular Diagnostics
- 8.5.1 Overview
- 8.5.2 Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Microbiology
- 8.6.1 Overview
- 8.6.2 Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.7 Blood Glucose Self-Monitoring
- 8.7.1 Overview
- 8.7.2 Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.8 Coagulation and Hemostasis
- 8.8.1 Overview
- 8.8.2 Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.9 Hematology
- 8.9.1 Overview
- 8.9.2 Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.10 Urinalysis
- 8.10.1 Overview
- 8.10.2 Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.11 Others
- 8.11.1 Overview
- 8.11.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application
- 9.1 Overview
- 9.2 In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
- 9.3 Infectious Disease
- 9.3.1 Overview
- 9.3.2 Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Diabetes
- 9.4.1 Overview
- 9.4.2 Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Cardiology
- 9.6.1 Overview
- 9.6.2 Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 9.7 Autoimmune Diseases
- 9.7.1 Overview
- 9.7.2 Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 9.8 Nephrology
- 9.8.1 Overview
- 9.8.2 Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User
- 10.1 Overview
- 10.2 In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
- 10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Laboratories
- 10.4.1 Overview
- 10.4.2 Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 10.5 Homecare
- 10.5.1 Overview
- 10.5.2 Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis
- 11.1 North America: In-Vitro Diagnostics Market
- 11.1.1 Overview
- 11.1.2 North America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.7 North America: In-Vitro Diagnostics Market, by Country
- 11.1.7.1 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.7.1.1 Overview
- 11.1.7.1.2 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.7.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.1.7.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.7.1.5 US: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.1.7.1.6 US: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.7.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.7.2.1 Overview
- 11.1.7.2.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.7.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.1.7.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.7.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.1.7.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.7.3 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.7.3.1 Overview
- 11.1.7.3.2 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.7.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.1.7.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.7.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.1.7.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.7.1 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2 Europe: In-Vitro Diagnostics Market
- 11.2.1 Overview
- 11.2.2 Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.3 Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.2.4 Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.2.5 Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.2.6 Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.2.7 Europe: In-Vitro Diagnostics Market, by Country
- 11.2.7.1 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.1.1 Overview
- 11.2.7.1.2 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.1.3 Germany: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.2.7.1.4 Germany: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.2.7.1.5 Germany: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.2.7.1.6 Germany: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.2.7.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.2.1 Overview
- 11.2.7.2.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.2.3 France: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.2.7.2.4 France: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.2.7.2.5 France: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.2.7.2.6 France: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.2.7.3 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.3.1 Overview
- 11.2.7.3.2 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.3.3 UK: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.2.7.3.4 UK: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.2.7.3.5 UK: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.2.7.3.6 UK: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.2.7.4 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.4.1 Overview
- 11.2.7.4.2 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.4.3 Italy: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.2.7.4.4 Italy: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.2.7.4.5 Italy: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.2.7.4.6 Italy: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.2.7.5 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.5.1 Overview
- 11.2.7.5.2 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.5.3 Spain: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.2.7.5.4 Spain: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.2.7.5.5 Spain: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.2.7.5.6 Spain: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.2.7.6 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.6.1 Overview
- 11.2.7.6.2 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.7.6.3 Rest of Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.2.7.6.4 Rest of Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.2.7.6.5 Rest of Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.2.7.6.6 Rest of Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.2.7.1 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3 Asia Pacific: In-Vitro Diagnostics Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.3 Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.3.4 Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.3.5 Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.3.6 Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.3.7 Asia Pacific: In-Vitro Diagnostics Market, by Country
- 11.3.7.1 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.1.1 Overview
- 11.3.7.1.2 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.1.3 China: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.3.7.1.4 China: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.3.7.1.5 China: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.3.7.1.6 China: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.3.7.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.2.1 Overview
- 11.3.7.2.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.2.3 Japan: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.3.7.2.4 Japan: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.3.7.2.5 Japan: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.3.7.2.6 Japan: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.3.7.3 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.3.1 Overview
- 11.3.7.3.2 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.3.3 India: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.3.7.3.4 India: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.3.7.3.5 India: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.3.7.3.6 India: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.3.7.4 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.4.1 Overview
- 11.3.7.4.2 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.4.3 Australia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.3.7.4.4 Australia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.3.7.4.5 Australia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.3.7.4.6 Australia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.3.7.5 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.5.1 Overview
- 11.3.7.5.2 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.5.3 South Korea: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.3.7.5.4 South Korea: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.3.7.5.5 South Korea: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.3.7.5.6 South Korea: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.3.7.6 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.6.1 Overview
- 11.3.7.6.2 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.7.6.3 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.3.7.6.4 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.3.7.6.5 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.3.7.6.6 Rest of Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.3.7.1 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4 Middle East & Africa: In-Vitro Diagnostics Market
- 11.4.1 Overview
- 11.4.2 Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.3 Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.4.4 Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.4.5 Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.4.6 Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.4.7 Middle East & Africa: In-Vitro Diagnostics Market, by Country
- 11.4.7.1 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.7.1.1 Overview
- 11.4.7.1.2 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.7.1.3 South Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.4.7.1.4 South Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.4.7.1.5 South Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.4.7.1.6 South Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.4.7.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.7.2.1 Overview
- 11.4.7.2.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.7.2.3 Saudi Arabia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.4.7.2.4 Saudi Arabia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.4.7.2.5 Saudi Arabia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.4.7.2.6 Saudi Arabia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.4.7.3 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.7.3.1 Overview
- 11.4.7.3.2 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.7.3.3 UAE: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.4.7.3.4 UAE: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.4.7.3.5 UAE: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.4.7.3.6 UAE: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.4.7.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.7.4.1 Overview
- 11.4.7.4.2 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.7.4.3 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.4.7.4.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.4.7.4.5 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.4.7.4.6 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.4.7.1 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5 South & Central America: In-Vitro Diagnostics Market
- 11.5.1 Overview
- 11.5.2 South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.3 South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.5.4 South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.5.5 South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.5.6 South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.5.7 South & Central America: In-Vitro Diagnostics Market, by Country
- 11.5.7.1 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.7.1.1 Overview
- 11.5.7.1.2 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.7.1.3 Brazil: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.5.7.1.4 Brazil: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.5.7.1.5 Brazil: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.5.7.1.6 Brazil: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.5.7.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.7.2.1 Overview
- 11.5.7.2.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.7.2.3 Argentina: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.5.7.2.4 Argentina: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.5.7.2.5 Argentina: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.5.7.2.6 Argentina: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.5.7.3 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.7.3.1 Overview
- 11.5.7.3.2 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.7.3.3 Rest of South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.5.7.3.4 Rest of South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.5.7.3.5 Rest of South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.5.7.3.6 Rest of South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.5.7.1 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
12. Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in North America In-Vitro Diagnostics Market
- 12.3 Organic Developments
- 12.3.1 Overview
- 12.4 Inorganic Developments
- 12.4.1 Overview
13. Company Profiles
- 13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 F. Hoffmann-La Roche Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Danaher Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Siemens AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Sysmex Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Thermo Fisher Scientific Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Becton Dickinson and Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 bioMerieux SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Bio-Rad Laboratories Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Qiagen NV
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
- 14.1 About Us
- 14.2 Glossary of Terms
